FDA fast-tracks EO2463 immunotherapy for follicular lymphoma, promising a new treatment option backed by positive trial data ...

A study published in Cancer Discovery finds that combining an epigenetic therapy with an anti-PD-1 antibody, which uses the ...

A phase 1 clinical trial co-led by researchers at WashU Medicine found that a new type of cell-based immunotherapy was safe for patients with several types of B-cell lymphoma, a type of blood cancer.

Various treatments are available for lymphoma, including chemotherapy, radiation, immunotherapy, targeted therapy, or a bone marrow transplant. A doctor or specialist can recommend which treatment is ...

An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, including those as young as 12, according to a new clinical trial. The regimen, ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...

Imagine that your immune system could be educated so that it was able to recognize specific diseases and then destroy them. Science fiction? Or perhaps futuristic? Not anymore. Health Canada recently ...

Infections are the cause of more than half of all non-relapse-related deaths after chimeric antigen receptor T-cell immunotherapy for lymphoma and multiple myeloma patients, according to a study ...

Discover innovative immunotherapy strategies that leverage the immune system to combat hematological malignancies effectively ...